首页> 外文期刊>Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation >Impact of Daptomycin Minimum Inhibitory Concentration (MIC) on Outcomes of Patients with Hematologic Malignancies and Hematopoietic Stem Cell Transplant (HSCT) Recipients with Vancomycin-Resistant Enterococci (VRE) Bloodstream Infection (BSI)

【24h】

Impact of Daptomycin Minimum Inhibitory Concentration (MIC) on Outcomes of Patients with Hematologic Malignancies and Hematopoietic Stem Cell Transplant (HSCT) Recipients with Vancomycin-Resistant Enterococci (VRE) Bloodstream Infection (BSI)

机译：达托霉素最低抑菌浓度（MIC）对耐万古霉素肠球菌（VRE）血液感染（BSI）的血液系统恶性肿瘤和造血干细胞移植（HSCT）患者的结局的影响

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation》 |2015年第1期|共1页
作者
Chong Pearlie P.; van Duin David; Bangdiwala Ananta; Ivanova Anastasia; Kerr Alan; Weber David J.; Gilligan Peter H.; Khan Tippu; Shea Thomas C.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类治疗学;
关键词

相似文献

外文文献
中文文献
专利

1. Impact of Daptomycin Minimum Inhibitory Concentration (MIC) on Outcomes of Patients with Hematologic Malignancies and Hematopoietic Stem Cell Transplant (HSCT) Recipients with Vancomycin-Resistant Enterococci (VRE) Bloodstream Infection (BSI) [J] . Chong Pearlie P., van Duin David, Bangdiwala Ananta, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2015,第2Suppla1期

机译：达托霉素最低抑菌浓度（MIC）对耐万古霉素肠球菌（VRE）血液感染（BSI）的血液系统恶性肿瘤和造血干细胞移植（HSCT）患者的结局的影响
2. Prediction of Bloodstream Infection Due to Vancomycin-Resistant Enterococcus in Patients with Hematological Malignancy Undergoing Induction Therapy or Hematopoietic Stem Cell Transplant [J] . Webb Brandon, Healy Regan, Majers Jacob, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2016,第3Suppla1期

机译：接受诱导疗法或造血干细胞移植的恶性血液病患者因万古霉素耐药肠球菌引起的血流感染的预测
3. Daptomycin therapy for vancomycin-resistant enterococcus bacteremia in neutropenic patients with hematologic malignancies and hematopoietic cell transplantation recipients [J] . OtsukaM., Kharfan-DabajaM.A., WetzsteinG.A., Infectious diseases in clinical practice: IDCP . 2012,第5期

机译：达托霉素治疗中性粒细胞减少症血液系统恶性肿瘤和造血细胞移植受者的万古霉素耐药肠球菌菌血症
4. HIGH DOSE THERAPY WITH AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) FOR PATIENTS WITH PRIMARY SYSTEMIC AMYLOIDOSIS (AL): AN ABMTR STUDY [C] . DH Vesole, W Perez, D Reece, International Symposium on Amyloidosis . 2005

机译：具有自体造血干细胞移植（HSCT）的高剂量治疗用于初级全身淀粉样蛋白症（AL）的患者：ABMTR研究
5. The burden of parainfluenza virus infection in patients with hematological malignancy and hematopoietic stem cell transplant (HSCT) recipients in the absence of active immunization and approved therapy: The role of infection control. [D] . Hanmod, Santosh S. 2009

机译：在没有积极免疫和批准治疗的情况下，血液恶性肿瘤和造血干细胞移植（HSCT）患者的副流感病毒感染负担：感染控制的作用。
6. 2249. Impact of Minimum Inhibitory Concentration on Clinical Outcomes of Daptomycin for VRE Bloodstream Infection Among Neutropenic Oncology Patients [O] . Elisabeth Caulder, Elizabeth Palavecino, James Beardsley, -1

机译：2249.中性粒细胞减少性肿瘤患者中最小抑制浓度对达托霉素对VRE血液感染的临床结果的影响
7. Impact of Daptomycin Minimum Inhibitory Concentration (MIC) on Outcomes of Patients with Hematologic Malignancies and Hematopoietic Stem Cell Transplant (HSCT) Recipients with Vancomycin-Resistant Enterococci (VRE) Bloodstream Infection (BSI) [O] . Chong Pearlie P., van Duin David, Bangdiwala Ananta, 2015

机译：达托霉素最低抑菌浓度（MIC）对耐万古霉素肠球菌（VRE）血液感染（BSI）的血液系统恶性肿瘤和造血干细胞移植（HSCT）患者的结局的影响

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号